The government has restricted fixed-dose combinations containing Chlorpheniramine Maleate and Phenylephrine Hydrochloride. These medicines are now prohibited for use in children below four years of age. Manufacturers must clearly display a warning on all associated product packaging. This action follows recommendations from an expert committee and the Drugs Technical Advisory Board. The notification is effective from its publication date in the official gazette.

Government restricts chlorpheniramine-phenylephrine combination drugs for children under four to ensure safety and public health.

Government restricts fixed dose combinations for young children, mandating warnings against use in those under four years old.